Stem cell therapy for acute respiratory distress syndrome
Part of Lungs & breathing clinical trials.
This trial tests a new stem cell treatment made from umbilical cord cells for people with ARDS, a serious lung condition. The treatment may help reduce inflammation and improve lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the hospital.
- You have been diagnosed with ARDS (a severe lung condition).
- You are between 18 and 80 years old.
- Your oxygen levels are low and you need extra oxygen or a breathing machine.
- You have not been in the hospital for more than 4 days (96 hours) before joining.
- You have not been on a breathing tube for more than 2 days (48 hours) before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.